LIQUIDIA TECHNOLOGIES INC
NASDAQ: LQDA (Liquidia Corporation)
Kemas kini terakhir: 5 jam lalu80.89
3.81 (4.94%)
| Penutupan Terdahulu | 77.08 |
| Buka | 78.70 |
| Jumlah Dagangan | 1,069,859 |
| Purata Dagangan (3B) | 1,887,185 |
| Modal Pasaran | 7,193,393,664 |
| Harga / Pendapatan (P/E TTM) | 475.82 |
| Harga / Pendapatan (P/E Ke hadapan) | 19.42 |
| Harga / Jualan (P/S) | 24.09 |
| Harga / Buku (P/B) | 63.13 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Aug 2026 |
| Margin Operasi (TTM) | -1,135.42% |
| EPS Cair (TTM) | -1.71 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 297.04% |
| Nisbah Semasa (MRQ) | 2.93 |
| Aliran Tunai Operasi (OCF TTM) | -99.23 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -64.38 M |
| Pulangan Atas Aset (ROA TTM) | -37.66% |
| Pulangan Atas Ekuiti (ROE TTM) | -203.98% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Bercampur | Menaik |
| Drug Manufacturers - Specialty & Generic (Global) | Bercampur | Bercampur | |
| Stok | Liquidia Corporation | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -4.0 |
| Volatiliti Harga | -3.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | 0.5 |
| Purata | -1.25 |
|
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 13.64% |
| % Dimiliki oleh Institusi | 65.04% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Farallon Capital Management, L.L.C. | 31 Mar 2026 | 8,656,038 |
| Caligan Partners Lp | 31 Mar 2026 | 8,118,892 |
| Findell Capital Management Llc | 31 Mar 2026 | 3,502,112 |
| Opaleye Management Inc. | 31 Mar 2026 | 2,545,000 |
| Mpm Bioimpact Llc | 31 Mar 2026 | 1,405,158 |
| Caprock Group, Llc | 31 Mar 2026 | 1,367,235 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| ADAIR JASON | - | 71.21 | -7,863 | -559,924 |
| BLOCH STEPHEN M | - | 81.23 | -50,000 | -4,061,500 |
| BOYLE DANA | - | 71.21 | -9,002 | -641,032 |
| JEFFS ROGER | - | 71.21 | -35,249 | -2,510,081 |
| KASETA MICHAEL | - | 71.21 | -20,430 | -1,454,820 |
| KHINDRI SANJEEV | - | 71.21 | -1,185 | -84,384 |
| KREPP SARAH | - | 71.21 | -7,864 | -559,995 |
| MOOMAW SCOTT | - | 71.21 | -9,539 | -679,272 |
| SAGGAR RAJEEV | - | 71.21 | -9,926 | -706,830 |
| SCHUNDLER RUSSELL | - | 71.21 | -14,738 | -1,049,493 |
| Jumlah Keseluruhan Kuantiti Bersih | -165,796 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -12,307,333 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 72.21 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BOYLE DANA | Pegawai | 13 Jul 2026 | Jual automatik (-) | 9,002 | 71.21 | 641,032 |
| MOOMAW SCOTT | Pegawai | 13 Jul 2026 | Jual automatik (-) | 9,539 | 71.21 | 679,272 |
| SAGGAR RAJEEV | Pegawai | 13 Jul 2026 | Jual automatik (-) | 9,926 | 71.21 | 706,830 |
| SCHUNDLER RUSSELL | Pegawai | 13 Jul 2026 | Jual automatik (-) | 14,738 | 71.21 | 1,049,493 |
| ADAIR JASON | Pegawai | 13 Jul 2026 | Jual automatik (-) | 7,863 | 71.21 | 559,924 |
| JEFFS ROGER | Pegawai | 13 Jul 2026 | Jual automatik (-) | 35,249 | 71.21 | 2,510,081 |
| KASETA MICHAEL | Pegawai | 13 Jul 2026 | Jual automatik (-) | 20,430 | 71.21 | 1,454,820 |
| KHINDRI SANJEEV | Pegawai | 13 Jul 2026 | Jual automatik (-) | 1,185 | 71.21 | 84,384 |
| KREPP SARAH | Pegawai | 13 Jul 2026 | Jual automatik (-) | 7,864 | 71.21 | 559,995 |
| BOYLE DANA | Pegawai | 10 Jul 2026 | Pelaksanaan pilihan | 3,179 | - | - |
| MOOMAW SCOTT | Pegawai | 10 Jul 2026 | Pelaksanaan pilihan | 7,466 | - | - |
| SAGGAR RAJEEV | Pegawai | 10 Jul 2026 | Pelaksanaan pilihan | 8,018 | - | - |
| SCHUNDLER RUSSELL | Pegawai | 10 Jul 2026 | Pelaksanaan pilihan | 10,168 | - | - |
| ADAIR JASON | Pegawai | 10 Jul 2026 | Pelaksanaan pilihan | 10,251 | - | - |
| JEFFS ROGER | Pegawai | 10 Jul 2026 | Pelaksanaan pilihan | 28,167 | - | - |
| KASETA MICHAEL | Pegawai | 10 Jul 2026 | Pelaksanaan pilihan | 12,879 | - | - |
| KREPP SARAH | Pegawai | 10 Jul 2026 | Pelaksanaan pilihan | 3,179 | - | - |
| BLOCH STEPHEN M | Pengarah | 07 Jul 2026 | Jual (-) | 50,000 | 81.23 | 4,061,500 |
| Papar semua | ||||||
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |